Iurasidon Hydrochloride Intermedia CAS 14805-29-9 Munditia ≥99.0% (HPLC)
Manufacturer Supple Lurasidone Hydrochloride Related Intermedia:
(1R,2R)-1,2-Cyclohexanedimethanol CAS 65376-05-8
(3aR,4S,7R,7aS)-rel-Hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione CAS 14805-29-9
Iurasidone Hydrochloride CAS 367514-88-3 API
| Nomen chemicum | (3aR,4S,7R,7aS)-rel-hexahydro-4,7-methano-1H-isoindole-1,3(2H) |
| Synonyma | exo-2,3-Norbornanedicarboximide;Iurasidon Hydrochloride Medium |
| CAS Number | 14805-29-9 |
| CATTUS Number | RF-PI264 |
| Stock Status | In Stock, Productio Ascendite ad Tons |
| Formulae hypotheticae | C9H11NO2 |
| M. Pondus | 165.19 |
| Density | 1.285 |
| Shipping Condition | Uit sub Ambient Temperature ut Non Periculose Chemical |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Aspectus | Alba ad fere album pulveris |
| Liquescens punctum | 150.0~154.0℃ |
| Differentia | H-NMR |
| Related Compositum | ≤0.50% |
| Eudo Isomer | ≤0.15% |
| immunditiam A | ≤0.16% (3aR,4S,7R,7aS) 4,7-Methano-1H-isoindole-1,3(2H)-dione |
| Maximilianus.una immunditia | ≤0.30% |
| Totalis immunditias | ≤1.0% |
| Aqua Content | ≤1.0% |
| Metalla gravis | ≤20ppm |
| Puritas / Analysis Methodus | ≥99.0% (HPLC) |
| Test Standard | Enterprise Standard |
| Consuetudinem | Lurasidon Hydrochloridum (CAS 367514-88-3) Intermediate |
sarcina: Utrem, aluminium foil, pera, cardboard Drum, 25kg/Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, umore et peste infestatione.
Shanghai Ruifu Chemical Co., Ltd. est praecipuum fabricam et supplementum (3aR,4S,7R,7aS)-rel-Hexahydro-4,7-methano-1H-isoindole-1,3(2H) -29-9) magna qualitate, productio commercialis.Itmedium est typice in synthesi Lurasidonis Hydrochloridis (CAS 367514-88-3) in curatione Schizophreniae.
Iurasidone a FDA anno 2010 probata est pro schizophrenia et anno 2013 propter episodium depressivum cum turbatione bipolaris adiunctum.Iurasidone est substantia viva voce administrata ad classem medicamentorum antipsychoticorum atypicarum (AAPD).EMA in 2014 pro schizophrenia approbavit.Iurasidone etiam in pluribus regionibus extra US et EU, in Canada, inclusa, deductae sunt, ubi utrumque indicium approbatur.Fiunt per multi-gradum chemicum processum.
